nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0953	0.146	CbGbCtD
Delavirdine—CYP3A7—Sorafenib—thyroid cancer	0.0953	0.146	CbGbCtD
Delavirdine—CYP3A5—Sorafenib—thyroid cancer	0.0715	0.11	CbGbCtD
Delavirdine—CYP2C8—Sorafenib—thyroid cancer	0.0688	0.106	CbGbCtD
Delavirdine—CYP2C19—Sorafenib—thyroid cancer	0.0577	0.0886	CbGbCtD
Delavirdine—CYP1A2—Sorafenib—thyroid cancer	0.0532	0.0817	CbGbCtD
Delavirdine—CYP2C9—Sorafenib—thyroid cancer	0.048	0.0736	CbGbCtD
Delavirdine—CYP3A4—Vandetanib—thyroid cancer	0.0463	0.071	CbGbCtD
Delavirdine—CYP2D6—Sorafenib—thyroid cancer	0.0439	0.0673	CbGbCtD
Delavirdine—CYP3A4—Sorafenib—thyroid cancer	0.0279	0.0428	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—thyroid cancer	0.0266	0.0409	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—thyroid cancer	0.0169	0.026	CbGbCtD
Delavirdine—Constipation—Sorafenib—thyroid cancer	0.000454	0.0013	CcSEcCtD
Delavirdine—Pain—Sorafenib—thyroid cancer	0.000454	0.0013	CcSEcCtD
Delavirdine—Vascular purpura—Epirubicin—thyroid cancer	0.000446	0.00128	CcSEcCtD
Delavirdine—Hypertonia—Doxorubicin—thyroid cancer	0.000446	0.00128	CcSEcCtD
Delavirdine—Hepatic failure—Epirubicin—thyroid cancer	0.000444	0.00127	CcSEcCtD
Delavirdine—Mental disability—Doxorubicin—thyroid cancer	0.000441	0.00127	CcSEcCtD
Delavirdine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000434	0.00124	CcSEcCtD
Delavirdine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000433	0.00124	CcSEcCtD
Delavirdine—Renal failure acute—Epirubicin—thyroid cancer	0.000432	0.00124	CcSEcCtD
Delavirdine—Increased appetite—Epirubicin—thyroid cancer	0.000425	0.00122	CcSEcCtD
Delavirdine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000424	0.00122	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000423	0.00121	CcSEcCtD
Delavirdine—Urticaria—Sorafenib—thyroid cancer	0.000422	0.00121	CcSEcCtD
Delavirdine—Abdominal pain—Sorafenib—thyroid cancer	0.00042	0.0012	CcSEcCtD
Delavirdine—Body temperature increased—Sorafenib—thyroid cancer	0.00042	0.0012	CcSEcCtD
Delavirdine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000418	0.0012	CcSEcCtD
Delavirdine—Purpura—Epirubicin—thyroid cancer	0.000414	0.00119	CcSEcCtD
Delavirdine—Vascular purpura—Doxorubicin—thyroid cancer	0.000413	0.00118	CcSEcCtD
Delavirdine—Hepatic failure—Doxorubicin—thyroid cancer	0.000411	0.00118	CcSEcCtD
Delavirdine—Cardiac failure—Epirubicin—thyroid cancer	0.000409	0.00117	CcSEcCtD
Delavirdine—Lethargy—Epirubicin—thyroid cancer	0.000407	0.00117	CcSEcCtD
Delavirdine—Hyponatraemia—Epirubicin—thyroid cancer	0.000401	0.00115	CcSEcCtD
Delavirdine—Renal failure acute—Doxorubicin—thyroid cancer	0.0004	0.00115	CcSEcCtD
Delavirdine—Diplopia—Epirubicin—thyroid cancer	0.000399	0.00114	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000399	0.00114	CcSEcCtD
Delavirdine—Increased appetite—Doxorubicin—thyroid cancer	0.000393	0.00113	CcSEcCtD
Delavirdine—Migraine—Epirubicin—thyroid cancer	0.000393	0.00113	CcSEcCtD
Delavirdine—Affect lability—Epirubicin—thyroid cancer	0.000393	0.00113	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000391	0.00112	CcSEcCtD
Delavirdine—Hypersensitivity—Sorafenib—thyroid cancer	0.000391	0.00112	CcSEcCtD
Delavirdine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000386	0.00111	CcSEcCtD
Delavirdine—Purpura—Doxorubicin—thyroid cancer	0.000383	0.0011	CcSEcCtD
Delavirdine—Asthenia—Sorafenib—thyroid cancer	0.000381	0.00109	CcSEcCtD
Delavirdine—Cardiac failure—Doxorubicin—thyroid cancer	0.000378	0.00109	CcSEcCtD
Delavirdine—Mood swings—Epirubicin—thyroid cancer	0.000378	0.00108	CcSEcCtD
Delavirdine—Lethargy—Doxorubicin—thyroid cancer	0.000377	0.00108	CcSEcCtD
Delavirdine—Pruritus—Sorafenib—thyroid cancer	0.000375	0.00108	CcSEcCtD
Delavirdine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000374	0.00107	CcSEcCtD
Delavirdine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000371	0.00106	CcSEcCtD
Delavirdine—Diplopia—Doxorubicin—thyroid cancer	0.000369	0.00106	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000369	0.00106	CcSEcCtD
Delavirdine—Dry skin—Epirubicin—thyroid cancer	0.000366	0.00105	CcSEcCtD
Delavirdine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000364	0.00105	CcSEcCtD
Delavirdine—Migraine—Doxorubicin—thyroid cancer	0.000363	0.00104	CcSEcCtD
Delavirdine—Affect lability—Doxorubicin—thyroid cancer	0.000363	0.00104	CcSEcCtD
Delavirdine—Diarrhoea—Sorafenib—thyroid cancer	0.000363	0.00104	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000359	0.00103	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000359	0.00103	CcSEcCtD
Delavirdine—Gastritis—Epirubicin—thyroid cancer	0.000353	0.00101	CcSEcCtD
Delavirdine—Muscular weakness—Epirubicin—thyroid cancer	0.000352	0.00101	CcSEcCtD
Delavirdine—Dizziness—Sorafenib—thyroid cancer	0.000351	0.00101	CcSEcCtD
Delavirdine—Mood swings—Doxorubicin—thyroid cancer	0.00035	0.001	CcSEcCtD
Delavirdine—Abdominal distension—Epirubicin—thyroid cancer	0.000347	0.000996	CcSEcCtD
Delavirdine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000346	0.000992	CcSEcCtD
Delavirdine—Influenza—Epirubicin—thyroid cancer	0.000345	0.000989	CcSEcCtD
Delavirdine—Dysphagia—Epirubicin—thyroid cancer	0.000345	0.000989	CcSEcCtD
Delavirdine—Eosinophilia—Epirubicin—thyroid cancer	0.000341	0.00098	CcSEcCtD
Delavirdine—Dry skin—Doxorubicin—thyroid cancer	0.000338	0.000971	CcSEcCtD
Delavirdine—Pancreatitis—Epirubicin—thyroid cancer	0.000338	0.00097	CcSEcCtD
Delavirdine—Vomiting—Sorafenib—thyroid cancer	0.000337	0.000968	CcSEcCtD
Delavirdine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000337	0.000967	CcSEcCtD
Delavirdine—Rash—Sorafenib—thyroid cancer	0.000335	0.00096	CcSEcCtD
Delavirdine—Dermatitis—Sorafenib—thyroid cancer	0.000334	0.000959	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000332	0.000954	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000332	0.000954	CcSEcCtD
Delavirdine—Headache—Sorafenib—thyroid cancer	0.000332	0.000954	CcSEcCtD
Delavirdine—Bronchitis—Epirubicin—thyroid cancer	0.000332	0.000952	CcSEcCtD
Delavirdine—Pancytopenia—Epirubicin—thyroid cancer	0.000328	0.00094	CcSEcCtD
Delavirdine—Gastritis—Doxorubicin—thyroid cancer	0.000327	0.000937	CcSEcCtD
Delavirdine—Muscular weakness—Doxorubicin—thyroid cancer	0.000326	0.000934	CcSEcCtD
Delavirdine—Neutropenia—Epirubicin—thyroid cancer	0.000323	0.000925	CcSEcCtD
Delavirdine—Abdominal distension—Doxorubicin—thyroid cancer	0.000321	0.000922	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000321	0.00092	CcSEcCtD
Delavirdine—Influenza—Doxorubicin—thyroid cancer	0.000319	0.000915	CcSEcCtD
Delavirdine—Dysphagia—Doxorubicin—thyroid cancer	0.000319	0.000915	CcSEcCtD
Delavirdine—Eosinophilia—Doxorubicin—thyroid cancer	0.000316	0.000906	CcSEcCtD
Delavirdine—Nausea—Sorafenib—thyroid cancer	0.000315	0.000904	CcSEcCtD
Delavirdine—Weight increased—Epirubicin—thyroid cancer	0.000314	0.0009	CcSEcCtD
Delavirdine—Pancreatitis—Doxorubicin—thyroid cancer	0.000313	0.000898	CcSEcCtD
Delavirdine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000311	0.000893	CcSEcCtD
Delavirdine—Pneumonia—Epirubicin—thyroid cancer	0.000309	0.000887	CcSEcCtD
Delavirdine—Bronchitis—Doxorubicin—thyroid cancer	0.000307	0.00088	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000305	0.000875	CcSEcCtD
Delavirdine—Pancytopenia—Doxorubicin—thyroid cancer	0.000303	0.000869	CcSEcCtD
Delavirdine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000301	0.000865	CcSEcCtD
Delavirdine—Stomatitis—Epirubicin—thyroid cancer	0.0003	0.00086	CcSEcCtD
Delavirdine—Jaundice—Epirubicin—thyroid cancer	0.0003	0.00086	CcSEcCtD
Delavirdine—Conjunctivitis—Epirubicin—thyroid cancer	0.000299	0.000858	CcSEcCtD
Delavirdine—Urinary tract infection—Epirubicin—thyroid cancer	0.000299	0.000858	CcSEcCtD
Delavirdine—Neutropenia—Doxorubicin—thyroid cancer	0.000298	0.000856	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000297	0.000851	CcSEcCtD
Delavirdine—Haematuria—Epirubicin—thyroid cancer	0.000293	0.000841	CcSEcCtD
Delavirdine—Weight increased—Doxorubicin—thyroid cancer	0.00029	0.000833	CcSEcCtD
Delavirdine—Epistaxis—Epirubicin—thyroid cancer	0.00029	0.000832	CcSEcCtD
Delavirdine—Sinusitis—Epirubicin—thyroid cancer	0.000289	0.000828	CcSEcCtD
Delavirdine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000288	0.000826	CcSEcCtD
Delavirdine—Pneumonia—Doxorubicin—thyroid cancer	0.000286	0.000821	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000282	0.000809	CcSEcCtD
Delavirdine—Bradycardia—Epirubicin—thyroid cancer	0.000281	0.000806	CcSEcCtD
Delavirdine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000279	0.0008	CcSEcCtD
Delavirdine—Stomatitis—Doxorubicin—thyroid cancer	0.000277	0.000796	CcSEcCtD
Delavirdine—Jaundice—Doxorubicin—thyroid cancer	0.000277	0.000796	CcSEcCtD
Delavirdine—Rhinitis—Epirubicin—thyroid cancer	0.000277	0.000794	CcSEcCtD
Delavirdine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000277	0.000793	CcSEcCtD
Delavirdine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000277	0.000793	CcSEcCtD
Delavirdine—Hepatitis—Epirubicin—thyroid cancer	0.000276	0.000792	CcSEcCtD
Delavirdine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000275	0.000788	CcSEcCtD
Delavirdine—Pharyngitis—Epirubicin—thyroid cancer	0.000274	0.000786	CcSEcCtD
Delavirdine—Oedema peripheral—Epirubicin—thyroid cancer	0.000272	0.00078	CcSEcCtD
Delavirdine—Haematuria—Doxorubicin—thyroid cancer	0.000271	0.000778	CcSEcCtD
Delavirdine—Epistaxis—Doxorubicin—thyroid cancer	0.000268	0.00077	CcSEcCtD
Delavirdine—Sinusitis—Doxorubicin—thyroid cancer	0.000267	0.000766	CcSEcCtD
Delavirdine—Erythema multiforme—Epirubicin—thyroid cancer	0.000261	0.000749	CcSEcCtD
Delavirdine—Bradycardia—Doxorubicin—thyroid cancer	0.00026	0.000746	CcSEcCtD
Delavirdine—Tinnitus—Epirubicin—thyroid cancer	0.000257	0.000738	CcSEcCtD
Delavirdine—Rhinitis—Doxorubicin—thyroid cancer	0.000256	0.000735	CcSEcCtD
Delavirdine—Hepatitis—Doxorubicin—thyroid cancer	0.000255	0.000733	CcSEcCtD
Delavirdine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000254	0.000729	CcSEcCtD
Delavirdine—Pharyngitis—Doxorubicin—thyroid cancer	0.000254	0.000727	CcSEcCtD
Delavirdine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000252	0.000722	CcSEcCtD
Delavirdine—Chills—Epirubicin—thyroid cancer	0.000248	0.000711	CcSEcCtD
Delavirdine—Alopecia—Epirubicin—thyroid cancer	0.000244	0.0007	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000242	0.000693	CcSEcCtD
Delavirdine—Erythema—Epirubicin—thyroid cancer	0.00024	0.000689	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—thyroid cancer	0.00024	0.000689	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—thyroid cancer	0.000238	0.000683	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—thyroid cancer	0.000237	0.000679	CcSEcCtD
Delavirdine—Tension—Epirubicin—thyroid cancer	0.000236	0.000677	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—thyroid cancer	0.000235	0.000675	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—thyroid cancer	0.000233	0.00067	CcSEcCtD
Delavirdine—Back pain—Epirubicin—thyroid cancer	0.000232	0.000667	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—thyroid cancer	0.000231	0.000663	CcSEcCtD
Delavirdine—Chills—Doxorubicin—thyroid cancer	0.000229	0.000657	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—thyroid cancer	0.000226	0.00065	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—thyroid cancer	0.000226	0.000648	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000223	0.00064	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—thyroid cancer	0.000222	0.000638	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—thyroid cancer	0.000222	0.000638	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—thyroid cancer	0.000222	0.000637	CcSEcCtD
Delavirdine—Agitation—Epirubicin—thyroid cancer	0.000221	0.000634	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—thyroid cancer	0.000219	0.000629	CcSEcCtD
Delavirdine—Tension—Doxorubicin—thyroid cancer	0.000218	0.000626	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—thyroid cancer	0.000218	0.000625	CcSEcCtD
Delavirdine—Malaise—Epirubicin—thyroid cancer	0.000217	0.000622	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—thyroid cancer	0.000216	0.00062	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—thyroid cancer	0.000216	0.000619	CcSEcCtD
Delavirdine—Syncope—Epirubicin—thyroid cancer	0.000216	0.000618	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—thyroid cancer	0.000215	0.000617	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—thyroid cancer	0.000215	0.000617	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—thyroid cancer	0.000214	0.000613	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—thyroid cancer	0.000212	0.000609	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—thyroid cancer	0.000211	0.000606	CcSEcCtD
Delavirdine—Cough—Epirubicin—thyroid cancer	0.00021	0.000602	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—thyroid cancer	0.00021	0.000601	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—thyroid cancer	0.000207	0.000595	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000206	0.000592	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—thyroid cancer	0.000206	0.00059	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—thyroid cancer	0.000205	0.000587	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—thyroid cancer	0.000205	0.000587	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—thyroid cancer	0.000205	0.000587	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—thyroid cancer	0.000204	0.000586	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—thyroid cancer	0.000204	0.000585	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—thyroid cancer	0.000202	0.00058	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—thyroid cancer	0.000201	0.000575	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—thyroid cancer	0.0002	0.000574	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—thyroid cancer	0.0002	0.000573	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—thyroid cancer	0.000199	0.000572	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—thyroid cancer	0.000199	0.000571	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—thyroid cancer	0.000198	0.000567	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—thyroid cancer	0.000196	0.000564	CcSEcCtD
Delavirdine—Oedema—Epirubicin—thyroid cancer	0.000196	0.000563	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000195	0.000561	CcSEcCtD
Delavirdine—Infection—Epirubicin—thyroid cancer	0.000195	0.000559	CcSEcCtD
Delavirdine—Cough—Doxorubicin—thyroid cancer	0.000194	0.000557	CcSEcCtD
Delavirdine—Shock—Epirubicin—thyroid cancer	0.000193	0.000554	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000192	0.000551	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—thyroid cancer	0.000192	0.000551	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—thyroid cancer	0.000191	0.000549	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—thyroid cancer	0.000191	0.000547	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00019	0.000544	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—thyroid cancer	0.000189	0.000543	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—thyroid cancer	0.000189	0.000543	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—thyroid cancer	0.000189	0.000543	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—thyroid cancer	0.000189	0.000541	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—thyroid cancer	0.000187	0.000537	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—thyroid cancer	0.000187	0.000536	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—thyroid cancer	0.000185	0.000531	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—thyroid cancer	0.000183	0.000526	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—thyroid cancer	0.000183	0.000525	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—thyroid cancer	0.000181	0.000521	CcSEcCtD
Delavirdine—Infection—Doxorubicin—thyroid cancer	0.00018	0.000517	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000179	0.000513	CcSEcCtD
Delavirdine—Shock—Doxorubicin—thyroid cancer	0.000179	0.000512	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000178	0.00051	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—thyroid cancer	0.000177	0.000509	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—thyroid cancer	0.000177	0.000508	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—thyroid cancer	0.000176	0.000506	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—thyroid cancer	0.000176	0.000505	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000175	0.000503	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—thyroid cancer	0.000175	0.000502	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—thyroid cancer	0.000174	0.0005	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—thyroid cancer	0.000173	0.000496	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—thyroid cancer	0.000173	0.000495	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—thyroid cancer	0.00017	0.000489	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—thyroid cancer	0.00017	0.000486	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000169	0.000486	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—thyroid cancer	0.000169	0.000485	CcSEcCtD
Delavirdine—Pain—Epirubicin—thyroid cancer	0.000168	0.000481	CcSEcCtD
Delavirdine—Constipation—Epirubicin—thyroid cancer	0.000168	0.000481	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000165	0.000474	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—thyroid cancer	0.000164	0.000471	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—thyroid cancer	0.000163	0.000467	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—thyroid cancer	0.000162	0.000464	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—thyroid cancer	0.000162	0.000464	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—thyroid cancer	0.000161	0.000463	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00016	0.00046	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—thyroid cancer	0.00016	0.000458	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—thyroid cancer	0.000158	0.000453	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000157	0.000449	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—thyroid cancer	0.000156	0.000449	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—thyroid cancer	0.000156	0.000447	CcSEcCtD
Delavirdine—Pain—Doxorubicin—thyroid cancer	0.000155	0.000445	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—thyroid cancer	0.000155	0.000445	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—thyroid cancer	0.000155	0.000445	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—thyroid cancer	0.000155	0.000445	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00015	0.000429	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000148	0.000426	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—thyroid cancer	0.000144	0.000415	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—thyroid cancer	0.000144	0.000414	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—thyroid cancer	0.000143	0.000412	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—thyroid cancer	0.000143	0.000412	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—thyroid cancer	0.000141	0.000404	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—thyroid cancer	0.000139	0.000398	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—thyroid cancer	0.000134	0.000385	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000134	0.000384	CcSEcCtD
Delavirdine—Asthenia—Doxorubicin—thyroid cancer	0.00013	0.000374	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—thyroid cancer	0.00013	0.000372	CcSEcCtD
Delavirdine—Pruritus—Doxorubicin—thyroid cancer	0.000128	0.000368	CcSEcCtD
Delavirdine—Vomiting—Epirubicin—thyroid cancer	0.000125	0.000358	CcSEcCtD
Delavirdine—Diarrhoea—Doxorubicin—thyroid cancer	0.000124	0.000356	CcSEcCtD
Delavirdine—Rash—Epirubicin—thyroid cancer	0.000124	0.000355	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—thyroid cancer	0.000124	0.000354	CcSEcCtD
Delavirdine—Headache—Epirubicin—thyroid cancer	0.000123	0.000352	CcSEcCtD
Delavirdine—Dizziness—Doxorubicin—thyroid cancer	0.00012	0.000344	CcSEcCtD
Delavirdine—Nausea—Epirubicin—thyroid cancer	0.000116	0.000334	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—thyroid cancer	0.000115	0.000331	CcSEcCtD
Delavirdine—Rash—Doxorubicin—thyroid cancer	0.000114	0.000328	CcSEcCtD
Delavirdine—Dermatitis—Doxorubicin—thyroid cancer	0.000114	0.000328	CcSEcCtD
Delavirdine—Headache—Doxorubicin—thyroid cancer	0.000114	0.000326	CcSEcCtD
Delavirdine—Nausea—Doxorubicin—thyroid cancer	0.000108	0.000309	CcSEcCtD
